HMOX1 and metabolic dysfunction-associated steatotic liver disease: Li et al. have indicated that limonin was effective to alleviate non-alcoholic fatty liver disease through reducing lipid accumulation, inhibiting inflammation and oxidative stress, and the mechanism may depend on NRF2/HO-1 signaling pathway (28).